About Us

Corporate Profile

Micro Labs

Established in 1973, Micro Labs Limited is a multi-faceted healthcare organization with a proficient marketing team, state-of-the-art manufacturing facilities and R&D centres that are at par with international standards. All this, robustly backed by a strong distribution network and path-breaking research work has placed us amongst India's fast growing transnational healthcare organizations.

A privately held company, founded by late Mr. G. C. Surana, the company is under the leadership of Mr. Dilip Surana & Mr. Anand Surana.

Micro Labs occupies leading positions in select therapeutic areas like Cardiology, Diabetology, Ophthalmology, Dermatology, Pain / Analgesics etc.

Business Beliefs:
Micro Labs is built around four pillars of business beliefs which are:

  • Quality: A driving force for the organisation across the value chain
  • Ethics: Manage businesses by imbibing best practices of governance and Ethics
  • Customer Focus: Seek to understand customer needs and focus on Customer Satisfaction
  • Respect for People: Our most important belief: Respect people and their contribution

It is ranked amongst top 20 in India with a market share of 1.75% as per AIOCD-AWACS October 2020.

Domestic Operations:

Micro Labs contributes significantly to the healthcare needs of domestic market for over 4 decades now, growing at an annual compounded growth rate of 14%. The current marketing is structured into 22 divisions each of which is customized to deliver a promotional message to a certain class of specialty customer with over 6000 plus medical representatives covering around 250,000 doctors & 180,000 pharmacies.

Global Presence:

The group has presence in over 50 countries,with ground level operations in 25 countries, exporting all major dosages in every therapeutic segment. Micro Labs is building critical mass in existing markets & developing business in new market like USA, East Europe, North Africa and South & Central America and is well poised to achieve in the medium term status “BIG GENERIC COMPANY” in the global pharmaceutical space.

Awards and Recognitions:

Time and again, Micro Labs ingenious ways have been recognized and awarded. Our awards and recognitions include:

  • Pharmaceutical Industry of Excellence Award for the year 2020 instituted by IPA to recognise pharma industry
  • IPR Leadership Award 2020 for Excellence Contribution in the field of Patents
  • Awarded ‘Best Concern for Health 2016’ by World CSR Day-National CSR-Leadership Congress & Awards
  • Micro Labs is a regular recipient of IDMA Quality Excellence Awards, with a clean hat-trick of 3 awards in 2009, an unprecedented 4 awards in 2010, 3 awards in 2011, 4 consecutive awards in 2012 and 2 awards in 2013

Amidst our proud achievers is Dolo, an award-winning brand highly prescribed for fever management. Dolo-650 was recently awarded ' Most Trusted and Popular Pharmaceutical Brand 2019' by Times Group.

Our CMD, Mr. Dilip Surana was awarded with the 'Responsible Business Leader award 2019' by Responsible Business Leaders in Mumbai.

University of Azteca has conferred the honorary doctorate to our CMD Mr. Dilip Surana in pharmaceutical management.


Previous awards include:
  • Micro Labs awarded 'Best Concern for Health 2016' by World CSR Day-National CSR-Leadership
Congress & Awards:
  • Caripill was awarded Silver Award under the 'Acute' Category for 'New Introduction of the Year 2016 and Tenepride was awarded Bronze AWARD under the 'Chronic' Category for 'New Introduction of the Year 2016' by AWACS Marketing Excellence Awards 2016
  • Dolo-650 awarded as 'Asia's Greatest Brands 2016' by Asia One Magazine and PwC India
  • Brand Dolo was awarded India's Most Admired Brand 2015 by White Page International
  • Dolo won the Brand of the Year 2014 GOLD award and Amlong won Brand of the Year 2014 BRONZE Award at AWACS Marketing Excellence Awards 2014
  • Brand Dolo awarded as 'Brand of the Year 2013' at 6th Annual Pharmaceutical Leadership Summit 2013
  • Mr. Dilip Surana, CMD of Micro Labs Limited honoured as the 'CEO of the Year 2016' by World CSR Day and felicitated as 'Asia's Greatest Leaders 2016' presented by Asia One magazine and PwC India
  • Micro Labs Sikkim manufacturing unit bagged the prestigious Silver Award at 'India Manufacturing Excellence Awards (IMEA)' 2016 & 2017,held by Frost & Sullivan in association with The Economic Times
  • Micro Labs is a regular recipient of IDMA Quality Excellence Awards, with a clean hat-trick of 3 awards in 2009, an unprecedented 4 awards in 2010, 3 awards in 2011, 4 consecutive awards in 2012 and 2 awards in 2013
CSR Contribution:

The company is also at the forefront in social contribution, striving to be a model corporate citizen in terms of Environmental Protection & Social Initiatives with significant contributions in the areas of education and health. The Micro group runs a GDA foundation since 1994, which includes educational institutions – an undergraduate college and a management college called Surana College, a school called Surana Vidyalaya besides helping several clinics and hospitals.


  • Report adverse experiences with medications
  • Report serious adverse reactions. A reaction is serious when the patient outcome is:
    • Death
    • Life-threatening (real risk of dying)
    • Hospitalization (initial or prolonged)
    • Disability (significant, persistent or permanent)
    • Congenital anomaly
    • Required intervention to prevent permanent impairment or damage
  • Report even if:
    • You’re not certain the product caused adverse reaction
    • You don’t have all the details however point nos. 1, 5, 7, 8, 11, 15, 16 & 18 (see reverse) are essentially required.
  • Who can report:
    • Any health care professional (Doctors including Dentists, Nurses and Pharmacists).
  • Where to report:
    • After completing, please return this form to Micro Labs Ltd, Pharmacovigilance Cell
  • What happens to the submitted information:
    • Information provided in this form is handled in strict confidence. PV cell at Micro Labs will carry out causality analysis and the data is statistically analysed and finally submitted to CDSCO.


The patient’s identity is held in strict confidence and protected to the fullest extent. Programme staff is not expected to and will not disclose the reporter’s identity in response to a request from the public. Submission of a report does not constitute an admission that medical personnel or manufacturer or the product caused or contributed to the reaction.

Vision and Aspiration

Our vision is built around a desire to being not just the best, but a leader in the development, manufacture and sales of premium pharmaceutical products.

View more

Vision & Aspiration

Our History

The story of Micro Labs Limited cannot unfold without the story of our founder and inspirational leader, Mr. G C Surana.

View more

Our History

Global Presence

Micro Labs has been in a continuous stage of growth ever since it's founding years and continues to chart its course as a leader in the pharmaceutical vertical.

View more

Global Presence